CKD Bio Corp. Logo

CKD Bio Corp.

Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.

063160 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 서대문구 충정로 8, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CKD Bio Corp. is a biopharmaceutical company specializing in the development and manufacturing of probiotics and active pharmaceutical ingredients (APIs). Leveraging over 50 years of expertise in fermentation technology and chemical synthesis, the company's core activities include the production of fermentation-based APIs, such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. It also focuses on the research and development of next-generation probiotics through its dedicated microbiome research division. Additionally, CKD Bio provides Contract Manufacturing Organization (CMO) services for APIs and intermediates, utilizing its cGMP-certified production facilities. The company manages a fully integrated process from microbial strain development and fermentation to purification and final synthesis, aiming for global leadership in biotechnology.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CKD Bio Corp. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-17 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 7.4 KB

Automate Your Workflow. Get a real-time feed of all CKD Bio Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CKD Bio Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea 048530
Inventage Lab Inc. Logo
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea 389470
Ipsen Logo
Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.
France IPN
IRLAB Therapeutics Logo
Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.
Sweden IRLAB
ISU Abxis Co., Ltd. Logo
Developing antibody-based immunotherapies for oncology and rare diseases.
South Korea 086890
IVF HARTMANN Holding AG Logo
Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.
Switzerland VBSN
Japan Tissue Engineering Co., Ltd. Logo
Pioneers regenerative medicine with tissue products, CDMO services, and research models.
Japan 7774
Develops therapies for rare genetic diseases, CNS disorders, and regenerative medicine.
Japan 4552

Talk to a Data Expert

Have a question? We'll get back to you promptly.